[{"ATTACHMENTNAME":"228C08F1_8F65_458D_B6E8_80D9399961B7_165726.pdf","NEWS_DT":"2016-11-08T16:57:31","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pfizer Ltd has submitted to BSE a copy of \"Transcript of the tele conference call with the Analysts\".","SCRIP_CD":500680,"AGENDA_ID":1,"NEWSSUB":"Transcript of the tele conference call with the Analysts"},{"ATTACHMENTNAME":"8198EA0B_9F13_4212_A5C3_68A867E42B33_165813.pdf","NEWS_DT":"2016-08-09T16:58:20","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pfizer Ltd has submitted to BSE a copy of the transcript of the tele conference call with the analysts held on August 08, 2016.","SCRIP_CD":500680,"AGENDA_ID":1,"NEWSSUB":"Transcript of the tele conference call with the analysts"},{"ATTACHMENTNAME":"04282890_0507_464D_B12B_6B23A878262F_163149.pdf","NEWS_DT":"2016-05-07T16:31:56","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pfizer Ltd has informed BSE about the transcript of the tele conference call with the analysts held on May 6, 2016, to discuss the Company's financial performance for the quarter and the financial year ended March 31, 2016.","SCRIP_CD":500680,"AGENDA_ID":1,"NEWSSUB":"Transcript of the tele conference call with the analysts"},{"ATTACHMENTNAME":"45EBD7D9_1846_47C4_9BD8_7CD66CDED8CB_165427.pdf","NEWS_DT":"2017-02-02T16:55:28","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pfizer Ltd has submitted to BSE a copy of the transcript of the tele conference call with the analysts held on February 01, 2017, to discuss the Company's financial performance for the third quarter and nine months ended December 31, 2016.","SCRIP_CD":500680,"AGENDA_ID":1,"NEWSSUB":"Transcript of Tele conference call with analysts"},{"ATTACHMENTNAME":"db5745d1-8eac-4e5c-8daf-e12a267909b7.pdf","NEWS_DT":"2020-08-06T16:54:48.507","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')","SCRIP_CD":500680,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]